Drug Trial Radar · NCT07781657
Study to Test Effects and Safety of RO7568282 in Early Symptomatic Alzheimer's Disease
Last checked: Nov 19, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
450
Planned (sponsor's estimate)
Start
Nov 10, 2026
Primary completion
Nov 1, 2029
Study completion Nov 1, 2029
Sponsor
- Lead sponsor
- Hoffmann-La RocheRoche (Genentech) (RHHBY)
- Sponsor type
- Industry
- First posted
- Aug 24, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 50 years, up to 90 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study aims to compare the effects of RO7568282 versus a placebo in people in the early stages of Alzheimer's disease (AD).
Conditions
- Alzheimer's Disease
Interventions
RO7568282Drug
RO7568282 will be administered as specified in the protocol.
PlaceboDrug
RO7568282 matching placebo will be administered as specified in the protocol.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline to Week 72 in Clinical Dementia Rating, Sum of Boxes (CDR-SB)Time frame: From baseline up to Week 72
Locations
12 sites in 5 countries. Site status is shown where the registry gives one.
Alzheimer's Research and Treatment Center
Stuart, Florida · Recruiting
Alzheimer?s Research and Treatment Center
Wellington, Florida · Recruiting
Conquest Research, LLC
Winter Park, Florida · Recruiting
Basil Clinical
Laurelton, New York · Recruiting
Royal Prince Alfred Hospital
Camperdown, New South Wales, Australia · Recruiting
Royal Melbourne Hospital
Parkville, Victoria, Australia · Recruiting
Groupement Hospitalier Est - Hôpital Neurologique
Bron, France · Recruiting
Gerontopole
Toulouse, France · Recruiting
Klinikum rechts der Isar der TU München
München, Germany · Recruiting
O?rodek Badawczo-Naukowo-Dydaktyczny Chorób Ot?piennych w ?cinawie
Ścinawa, Poland · Recruiting
EUROMEDIS Sp z o o
Szczecin, Poland · Recruiting
NeuroProtect
Warsaw, Poland · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.